Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure

NCT04528004 is registered in ClinicalTrials.gov with University of Washington as lead sponsor.

NCT NCT04528004
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04528004 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
Lead sponsor
University of Washington
Phase
Phase 1
Overall status
Active, not recruiting
Start date
September 26, 2020
Completion date
July 31, 2025
Enrollment
32 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure nyha class iv, heart failure, systolic, metabolic disturbance